Home
>
National Drug Code (NDC)
>
BACITRACIN
BACITRACIN - 48102-007-35 - (BACITRACIN)
Drug Information of BACITRACIN
| Product NDC: | 48102-007 |
| Proprietary Name: | BACITRACIN |
| Non Proprietary Name: | BACITRACIN |
| Active Ingredient(s): | 500 [iU]/g & nbsp; BACITRACIN |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of BACITRACIN
| Product NDC: | 48102-007 |
| Labeler Name: | Fera Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA061212 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100111 |
Package Information of BACITRACIN
| Package NDC: | 48102-007-35 |
| Package Description: | 1 TUBE in 1 CARTON (48102-007-35) > 3.5 g in 1 TUBE |
NDC Information of BACITRACIN
| NDC Code | 48102-007-35 |
| Proprietary Name | BACITRACIN |
| Package Description | 1 TUBE in 1 CARTON (48102-007-35) > 3.5 g in 1 TUBE |
| Product NDC | 48102-007 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | BACITRACIN |
| Dosage Form Name | OINTMENT |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20100111 |
| Marketing Category Name | ANDA |
| Labeler Name | Fera Pharmaceuticals |
| Substance Name | BACITRACIN |
| Strength Number | 500 |
| Strength Unit | [iU]/g |
| Pharmaceutical Classes | Decreased Cell Wall Synthesis & Repair [PE] |
